Davos 2024: Facing a World without Antibiotics

TL;DR

Antimicrobial resistance demands urgent, coordinated action because it already causes about 1.3 million deaths annually and could cause 10 million per year by 2050 if the current course continues. The Davos 2024 discussion calls for stronger research incentives, prudent antibiotic use, better diagnostics, education, surveillance, and collaboration across government, business, academia, and civil society. Read on to understand the human impact and the proposed responses.

Transcript

I just wanted to take a couple of minutes to welcome you to this very important discussion on antimicrobial resistance this is one of the key topics for us for those of you who haven't met my name is sham bishen and I head of the Center for Health and healthc Care at the world economic Forum AMR is a key topic for us just recently few months ago we... Read More

Key Insights

• 🧑‍⚕️ AMR is a global health crisis, with increasing deaths and economic costs attributed to it.
• ❓ Collaboration and integration across sectors are essential for tackling AMR effectively.
• 😒 Incentives for the development of new antimicrobials and prudent use of antibiotics are crucial.
• 🎓 Improving education and awareness among healthcare providers and the general public is important.
• ❓ Enhanced diagnostics and surveillance systems can contribute to reducing the overuse of antibiotics.
• ❓ Inequity in resources and funding poses challenges for poorer countries in addressing AMR.
• 🌐 Political commitment, global coordination, and prioritizing AMR on the political agenda are necessary for progress.

Questions & Answers

Q: Why is antimicrobial resistance such an urgent global health issue?

Antimicrobial resistance directly causes about 1.3 million deaths each year, according to the discussion. If the current course continues, that figure could reach 10 million deaths annually by 2050, while the economic cost could rise to as much as $1 trillion by 2050.

Q: What does a world without effective antibiotics mean for patients?

It means people who need antibiotics may no longer have access to treatments that work against resistant infections. The panel warns that this threatens everyone who depends on effective antibiotics and could reverse gains in children’s health.

Q: Who is disproportionately affected by antimicrobial resistance?

Children carry a disproportionate share of deaths from antimicrobial resistance. Women are also particularly exposed because they are 27% more likely than men to receive an antibiotic prescription during their lifetime, partly because of sexual and reproductive health needs.

Q: What is the World Economic Forum doing about antimicrobial resistance?

The World Economic Forum launched a Global Future Council on antimicrobial resistance, co-chaired by Dame Sally Davis. Its platform also brings together the public and private sectors, academia, thought leaders, and civil society to coordinate action.

Q: Why is antimicrobial research and development underfunded?

The discussion says too few resources are reaching antimicrobial research and development because both push and pull incentives are insufficient. Grants, loans, philanthropic funding, government support, and advanced market commitments are presented as ways to encourage biotech and pharmaceutical companies to invest more.

Q: How can diagnostics and surveillance help address antimicrobial resistance?

Better diagnostics can distinguish viral infections from bacterial infections, helping reduce unnecessary antibiotic prescriptions. Wider access to diagnostics, their integration into healthcare systems, and stronger surveillance can support more prudent antibiotic use.

Q: What makes collaboration essential for tackling antimicrobial resistance?

The problem spans healthcare, research, financing, regulation, education, and antibiotic use, so no single sector can address it alone. The discussion calls for governments, businesses, academia, philanthropic organizations, and civil society to contribute resources and coordinate solutions.

Q: What major political opportunities could advance action on antimicrobial resistance?

The discussion identifies a United Nations General Assembly high-level meeting on antimicrobial resistance and attention from the G7 as important opportunities. Under Italy’s G7 presidency, antimicrobial resistance was named as one of three priority areas alongside pandemic preparedness and digital health, while G7 finance ministers were working on research incentives.

Summary & Key Takeaways

• AMR is a pressing global issue, causing 1.3 million deaths each year and projected to reach 10 million by 2050.

• The World Economic Forum is taking steps to address AMR through the launch of a Global Future Council on AMR co-chaired by Dame Sally Davis.

• Collaboration between the public and private sectors, academia, and civil societies is crucial for addressing AMR effectively.